Summary
A double blind controlled clinical trial was undertaken to test the effectiveness of oral hypoglycaemic drugs in improving blood glucose and plasma insulin levels of borderline diabetic patients. Between 1969 and 1971, 120 men aged 25 to 55 with borderline impairment of glucose tolerance according to standard criteria at 2 successive oral glucose tolerance tests entered the study. They were randomized into 4 groups according to treatment: dimethylbiguanide + glibenclamide (n=29), placebo B + glibenclamide (n=28), placebo S + dimethylbiguanide (n=30), placebo B + S (n= 33). In each group drugs were taken twice a day before breakfast and lunch at a total dosage of 1.7 g/ day dimethylbiguanide and/or 4 mg/day glibenclamide. Treatment was stopped after 2 years. Patients returned 2 months after entry into the trial, then every 4 months for 2 years. Treatment was continued up to each oral glucose tolerance test except before the last test (drugs stopped 15 days before). 29 patients weighed 20% or more over their ideal body weight and 23 between 10% and 20%. After a dietary survey, these men were subjected to a total colorie restricted diet according to their excess weight. Results indicate that during the 2 years of treatment, no significant lasting effect of the biguanide on blood glucose and plasma insulin levels was detectable. During the oral glucose tolerance test at 14 months in the groups receiving sulphonylurea a significant decrease of blood glucose levels was observed at 0, 180 and 240 min. Glibenclamide had no effect on weight reduction while biguanide administration was accompanied by a significant weight reduction.
Article PDF
Similar content being viewed by others
References
Pirart, J.: Diabete et complications dégénératives. Présentation d'une étude prospective portant sur 4400 cas observés entre 1947 et 1973. I. Diabète Métab.3, 97–107 (1977)
Pirart, J.: Diabete et complications dégénératives. Présentation d'une étude prospective portant sur 4400 cas observés entre 1947 et 1973. II. Diabète Métab.3, 173–182 (1977)
Job, D., Eschwege, E., Guyot-Argenton, C., Aubry, J.P., Tchobroutsky, G.: Effect of multiple daily insulin injections on the course of diabetic retinopathy. Diabetes25, 463–469 (1976)
Engerman, R. L.: Pathophysiology of diabetic retinopathy, p 194. Report of the national commission on Diabetes, Vol. 3, part 3. Dhew Publication No. (NIH) 76-1023. Washington, DC: Government Printing Office 1976
Hagg, E.: On the pathogenesis of glomerular lesions in the alloxen diabetic rat. Acta Med. Scand. [Suppl.]558, 1–31 (1974)
Mauer, S. M., Sutherland, D. E. R., Steffes, M. W., Leonard, R. J., Najarian, J. S., Michael, A. F., Brown, D. F.: Pancreatic islet transplantation. Diabetes23, 748–753 (1974)
Eschwege, E.: Short term effects (2 years) of oral treatment for diabetes on the borderline impairment of oral glucose tolerance test. Diabetologia10, 363 (1974)
Valleron, A. J., Aboulker, J.P., Papoz, L., Rathery, M.: Reproducibility of borderline 0–2 hrs OGTT. In: Diabetes epidemiology in Europe. H. Gutsche, H.-D. Holler (Ed.), p 109. Stuttgart: Thieme 1975
McDonald, G. W., Fisher, G. F., Burnham, C.: Reproducibility of the oral glucose tolerance test. Diabetes14, 473–480 (1965)
McDonald, G. W., Burnham, C., Lewis, W. F.: Reproducibility of glucose tolerance in 101 non-diabetic women. Public Health Rep.79, 353 (1969)
Beck, H., Job, D., Sebban, C., Vignalou, J.: Reproductibilité de la mesure de la glycémie chez le sujet âgé. Geront. Clin.15, 37–44 (1973)
Job, D., Papoz, L., Eschwege, E., Rosselin, G. E.: Reproducibility of the glucose and insulin response to identical oral glucose load performed one year apart. Diabete Métab.4, 95–101 (1978)
Hugget, A., Nixon, D. A.: Use of glucose oxidase peroxidase or O-dianisidine in the determination of blood and urine glucose. Lancet1957 II, 368
European Association for the Study of Diabetes: A Brief Account of the European Diabetes Epidemiology Study Group Recommendation and Research. Diabetologia6, 453–454 (1970)
Gutsche, H., Holler, H. D.: Diabetes epidemiology in Europe, p. 197. Stuttgart: Thieme 1975
Committee on Statistics on the American Diabetes Association: Standardization of the oral glucose tolerance test. Diabetes18, 299–310 (1969)
Eschwege, E., Valleron, A. J., Papoz, L., Pequignot, G., Rosselin, G. E.: Classification and choice of the blood glucose values during oral glucose tolerance test as selection criteria for clinical trial in diabetes prevention. Proceedings of the International Symposium on Diabetes Sofia 23–25, November 1970, p. 23. Publishing house of the Bulgarian Academy of Sciences 1972
Wilkerson, H. L. C.: Diagnosis oral glucose tolerance test, p. 31. In: Diabetes Mellitus — Diagnosis and Treatment. New York: American Diabetes Association 1964
Fitzgerald, M. G., Keen, H.: Diagnostic classification of diabetes. Br. Med. J.1964 I, 1586
Valleron, A. J., Eschwege, E., Papoz, L., Rosselin, G. E.: Agreement and discrepancy in the evaluation of normal and diabetic oral glucose tolerance test. Diabetes24, 585–593 (1975)
Documenta Geigy: Naturwissenschaftliche Tabellen, 6th Ed., p. 634. Basel: Jr Geigy, AG 1963
Rosselin, G. E., Dolais, J.: Application de la methode radio immunologique du dosage de l'insuline humaine et du dosage de l'hormone folliculo-stimulante humaine (HFSH), p. 189–217. Les isotopes. Applications biocliniques. Monographie annuelle de la Société Française de Biologie Clinique, 1967. Paris: Expansion Scientifique Française 1967
Lellouch, J., Lazar, P.: Méthodes statistiques en expérimentation biologique, p. 165. Paris: Flammarion médecine-sciences 1974
Feldman, R., Crawford, D., Elashoff, R., Glass, A.: Oral Hypoglycemic drugs prophylaxis in asymptomatic diabetes. In: Diabetes, proceedings of the 8th congress of the IDF. W. J. Malaisse, J. Pirart, J. Vallance-Owen (Ed.), p. 574. Amsterdam: Excerpta Medica; New York: American Elsevier Publishing Company, Inc. 1974
Mehnert, H.: The biguanides: mechanism of action and clinical application. In: Diabetes, proceedings of the 8th congress of the IDF. W. J. Malaisse, J. Pirart, J. Vallance-Owen (Ed.), p. 603. Amsterdam: Excerpta Medica; New York: American Elsevier Publishing Company, Inc. 1974
Soeldner, J. S., Gleason, R. E., Williams, R. F., Garcia, M. J., Bearwood, D. M., Marble, A.: Diminished serum insulin response to glucose in genetic prediabetic males with normal glucose tolerance. Diabetes17, 17–26 (1968)
Colwell, J. A., Lein, A.: Diminished insulin response to hyperglycemia in prediabetes and diabetes. Diabetes16, 560–565 (1967)
Chu, P., Conway, M. J., Krouse, H. A., Goodner, C. J.: The pattern of response of plasma insulin and glucose to meals and fasting during chlorpropamide therapy. Ann. Intern. Med.68, 757 (1968)
Prout, T. E.: Adverse effects of oral hypoglycemic drugs. In: Diabetes, Proceedings of the 8th congress of IDF. W. J. Malaisse, J. Pirart, J. Vallance-Owen (Ed.), p. 612. Amsterdam: Excerpta Medica; New York: American Elsevier Publishing Company, Inc. 1974
Klimt, C. R., Meinert, C. L., Miller, C. L., Knowles, H. C.: UGDP, A study of relationships of therapy to vascular and other complications of diabetes. In: Tolbutamide after ten years, p. 261. Brook/Lodge symposium, August 1967. New York: Excerpta Medica Found. Int. Congr. Series No. 149 1967
UGDP: I Design, methods and baseline characteristics — II Mortality results. Diabetes19 (Suppl. 2), 747–789 (1970)
UGDP: V Evaluation of phenformin therapy. Diabetes24 (Suppl. 1), 65–184 (1974)
British Diabetes Association: Diagnostic criteria for diabetes mellitus. Recommendations, Medical and Scientific section, April 1978
Fajans, S. S., Conn, J. S.: Prediabetes, subclinical diabetes and latent clinical diabetes. Interpretation, diagnosis and treatment. In: on the Nature and Treatment of Diabetes, p. 641. New York: Excerpta Medica Found. Int. Congr. Series No. 84 1965
McDonald, G. W., Hoet, J. P., Butterfield, W. J. H.: Diabetes Mellitus: Report of WHO expert commitee. WHO Rep. Series No. 310 (1965)
Clarke, B. F., Campbell, I. W.: Comparison of metformin and chlorpropamide in non-obese, maturity-onset diabetics uncontrolled by diet. Br. Med. J.1977 II, 1576–1578
Keen, H., Jarrett, R. J., Fuller, J. H.: Tolbutamide and arterial disease in borderline diabetics. In: Proceedings of 8th Congress of the Int. Diab. Fed, W. J. Malaisse, J. Pirart (Eds.), p. 588. Amsterdam: Excerpta Medica 1974
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Papoz, L., Job, D., Eschwege, E. et al. Effect of oral hypoglycaemic drugs on glucose tolerance and insulin secretion in borderline diabetic patients. Diabetologia 15, 373–380 (1978). https://doi.org/10.1007/BF01219646
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01219646